meta name="publication-media-verification"content="1ebe9089d92647b3b88294de308625d5
Author Interviews, JAMA / 11.04.2014

MedicalResearch.com Interview with: Wei-ping Zhou, MD, PhD Department of Hepatic Surgery Eastern Hepatobiliary Surgery Hospital Shanghai, China MedicalResearch.com: What are the main findings of the study?  Answer:  The main finding is that Quantitative HBsAg can be used as a new prognostic factor of Hepatocellular Carcinoma recurrence after partial hepatectomy in patients with a low HBV-DNA level. (more…)